Skip to main content

Published locations for Abemaciclib becomes first CDK inhibitor to clinch single-agent approval for breast cancer

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Abemaciclib becomes first CDK inhibitor to clinch single-agent approval for breast cancer

User login

  • Reset your password
  • /content/abemaciclib-becomes-first-cdk-inhibitor-clinch-single-agent-approval-breast-cancer
  • /jcso/article/158890/breast-cancer/abemaciclib-becomes-first-cdk-inhibitor-clinch-single-agent
  • /hematology-oncology/article/158890/breast-cancer/abemaciclib-becomes-first-cdk-inhibitor-clinch
  • /breast-cancer-icymi/article/158890/breast-cancer/abemaciclib-becomes-first-cdk-inhibitor-clinch